ArticleMaterials today. Bio2023

Albumin-based formononetin nanomedicines for lung injury and fibrosis therapy via blocking macrophage pyroptosis.

Boshu Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.